However, the results of the aforementioned plasma IGF-1 investigation found no variations in plasma IGF-1 concentrations between patients in the OSAHS and control groups among different AHI scores and sample testing methodologies. The gene discussed is IGF1; the disease is obstructive sleep apnea syndrome.